Loading...
Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non–Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases
IMPORTANCE: Purpuric skin lesions have only rarely been reported in patients receiving epidermal growth factor receptor inhibitors. However, their clinical and histopathologic presentations have varied considerably. OBJECTIVE: To characterize purpuric skin eruptions caused by epidermal growth factor...
Na minha lista:
| Udgivet i: | JAMA Dermatol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817454/ https://ncbi.nlm.nih.gov/pubmed/28538945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.0903 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|